FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128839059> ?p ?o ?g. }

• W3128839059 endingPage "14" @default.
• W3128839059 startingPage "4" @default.
• W3128839059 abstract "Abstract Hepatocellular carcinoma (HCC) is one of the most prevalent cancers worldwide. Unfortunately, many patients are diagnosed at a late stage with a delay in the optimal timing for tumor resection. Transarterial chemoembolization (TACE) is currently considered the standard of care for patients with unresectable HCC Barcelona system class B classification. However, the treatment response of HCC patients to TACE varies widely, and there is no reliable marker for predicting a patient's response to TACE. Thus, the identification of patients who are sensitive or resistant to TACE is important for individualized therapy. Recently, our understanding of cancer cell biology has progressed enormously. Much of this progress has been driven by technological advances enabling previously unachievable studies to be performed and yield a constantly evolving picture of the regulatory role of noncoding RNAs (ncRNAs) in tumor biology. MicroRNAs (miRNAs) are a class of ncRNA molecules that regulate nearly one‐third of all protein‐coding RNAs. The existing literature indicates that the deregulation of miRNAs can contribute to tumorigenesis and metastasis in multiple cancers, including HCC, via the control of cell proliferation, apoptosis, invasion, or metastasis. Analysis and evaluation of this type of regulatory RNA could shed new light on the behavior of many cancers and provide new diagnostic and prognostic biomarkers as well as pharmacological targets for novel treatment strategies. To this end, this review highlights the expression and functional roles of miRNAs in TACE‐treated HCC and explores the potential applications of miRNAs as diagnostic markers and therapeutic targets." @default.
• W3128839059 created "2021-02-15" @default.
• W3128839059 creator A5048465962 @default.
• W3128839059 creator A5061780884 @default.
• W3128839059 date "2021-02-04" @default.
• W3128839059 modified "2023-09-24" @default.
• W3128839059 title "MicroRNA signatures as predictive biomarkers in transarterial chemoembolization‐treated hepatocellular carcinoma" @default.
• W3128839059 cites W1482814115 @default.
• W3128839059 cites W1514682825 @default.
• W3128839059 cites W1542862687 @default.
• W3128839059 cites W1560761903 @default.
• W3128839059 cites W1584843291 @default.
• W3128839059 cites W1609044025 @default.
• W3128839059 cites W1923097273 @default.
• W3128839059 cites W1972492327 @default.
• W3128839059 cites W1981889510 @default.
• W3128839059 cites W1984596305 @default.
• W3128839059 cites W1987851658 @default.
• W3128839059 cites W1992398113 @default.
• W3128839059 cites W1992710380 @default.
• W3128839059 cites W1996865412 @default.
• W3128839059 cites W1999787016 @default.
• W3128839059 cites W1999869217 @default.
• W3128839059 cites W2000019417 @default.
• W3128839059 cites W2001200491 @default.
• W3128839059 cites W2003628270 @default.
• W3128839059 cites W2004166300 @default.
• W3128839059 cites W2004791359 @default.
• W3128839059 cites W2008271972 @default.
• W3128839059 cites W2013577132 @default.
• W3128839059 cites W2014007818 @default.
• W3128839059 cites W2017857120 @default.
• W3128839059 cites W2019464570 @default.
• W3128839059 cites W2019873126 @default.
• W3128839059 cites W2021407107 @default.
• W3128839059 cites W2022013872 @default.
• W3128839059 cites W2028731100 @default.
• W3128839059 cites W2033857297 @default.
• W3128839059 cites W2036298536 @default.
• W3128839059 cites W2039550250 @default.
• W3128839059 cites W2043162780 @default.
• W3128839059 cites W2045842462 @default.
• W3128839059 cites W2050674265 @default.
• W3128839059 cites W2052160959 @default.
• W3128839059 cites W2054371348 @default.
• W3128839059 cites W2056574266 @default.
• W3128839059 cites W2057378223 @default.
• W3128839059 cites W2061291622 @default.
• W3128839059 cites W2065543285 @default.
• W3128839059 cites W2068451863 @default.
• W3128839059 cites W2069818879 @default.
• W3128839059 cites W2072993593 @default.
• W3128839059 cites W2074574205 @default.
• W3128839059 cites W2082873628 @default.
• W3128839059 cites W2092095172 @default.
• W3128839059 cites W2092893283 @default.
• W3128839059 cites W2095004208 @default.
• W3128839059 cites W2095949640 @default.
• W3128839059 cites W2099558746 @default.
• W3128839059 cites W2107515690 @default.
• W3128839059 cites W2108203277 @default.
• W3128839059 cites W2113660458 @default.
• W3128839059 cites W2113872487 @default.
• W3128839059 cites W2114406389 @default.
• W3128839059 cites W2114658861 @default.
• W3128839059 cites W2119582125 @default.
• W3128839059 cites W2129135114 @default.
• W3128839059 cites W2134896806 @default.
• W3128839059 cites W2145557885 @default.
• W3128839059 cites W2145720555 @default.
• W3128839059 cites W2154278191 @default.
• W3128839059 cites W2158456188 @default.
• W3128839059 cites W2159268982 @default.
• W3128839059 cites W2159659581 @default.
• W3128839059 cites W2159807040 @default.
• W3128839059 cites W2161039825 @default.
• W3128839059 cites W2161163389 @default.
• W3128839059 cites W2161514170 @default.
• W3128839059 cites W2228893886 @default.
• W3128839059 cites W2319133637 @default.
• W3128839059 cites W2342513208 @default.
• W3128839059 cites W2346744736 @default.
• W3128839059 cites W2402009455 @default.
• W3128839059 cites W2419986346 @default.
• W3128839059 cites W2461958627 @default.
• W3128839059 cites W2485821492 @default.
• W3128839059 cites W2514183797 @default.
• W3128839059 cites W2542206734 @default.
• W3128839059 cites W2598444026 @default.
• W3128839059 cites W2652256693 @default.
• W3128839059 cites W2691511139 @default.
• W3128839059 cites W2751453676 @default.
• W3128839059 cites W2765268860 @default.
• W3128839059 cites W2768701455 @default.
• W3128839059 cites W2889981809 @default.
• W3128839059 cites W2892196248 @default.
• W3128839059 cites W4230926765 @default.
• W3128839059 doi "https://doi.org/10.1002/prm2.12031" @default.

• next